Cargando…
DYRK1A Protein, A Promising Therapeutic Target to Improve Cognitive Deficits in Down Syndrome
Down syndrome (DS) caused by a trisomy of chromosome 21 (HSA21), is the most common genetic developmental disorder, with an incidence of 1 in 800 live births. Its phenotypic characteristics include intellectual impairment, early onset of Alzheimer’s disease, congenital heart disease, hypotonia, musc...
Autores principales: | Feki, Anis, Hibaoui, Youssef |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6210095/ https://www.ncbi.nlm.nih.gov/pubmed/30332747 http://dx.doi.org/10.3390/brainsci8100187 |
Ejemplares similares
-
Concise Review: Methods and Cell Types Used to Generate Down Syndrome Induced Pluripotent Stem Cells
por: Hibaoui, Youssef, et al.
Publicado: (2015) -
Targeting trisomic treatments: optimizing Dyrk1a inhibition to improve Down syndrome deficits
por: Stringer, Megan, et al.
Publicado: (2017) -
Human Pluripotent Stem Cells: Applications and Challenges in Neurological Diseases
por: Hibaoui, Youssef, et al.
Publicado: (2012) -
Human pluripotent stem cells as alternative models to study trophoblast development
por: Hibaoui, Youssef, et al.
Publicado: (2013) -
Organoid Models of Human Endometrial Development and Disease
por: Hibaoui, Youssef, et al.
Publicado: (2020)